In terms of tolerability, tirzepatide generally causes fewer gastrointestinal side effects, making it a better option for those sensitive to nausea, while Semaglutide GLP-1 may cause mild to moderate gastrointestinal issues like nausea and diarrhea, which usually subside over time
Also, we discovered that lower SIRT1 levels hastened primordial follicle loss and follicular dormancy, which impacted the destiny of primordial follicles, and increased oxidative stress and harm to DNA, resulting in mitochondrial malfunction
However, healthy habits established during treatment significantly improve long-term outcomes, and some people maintain their weight after stopping
Cell protection Reply 1 person found this helpful
In 2024, West Virginia launched a pilot providing Wegovy to 1,000 state employees and dependents
It was a 62-year-old who has been on grey-market retatrutide for a year and a half, longer than any participant in the completed trials, dosing herself off the published protocol, and who has never told her doctor any of it
